Telotristat Etiprate, a Novel Serotonin Synthesis Inhibitor, in Patients with Carcinoid Syndrome and Diarrhea Not Adequately Controlled by Octreotide

Serotonin produced by neuroendocrine tumors is believed to be a principal cause of the diarrhea in carcinoid syndrome. We assessed the safety and efficacy of telotristat etiprate, an oral serotonin synthesis inhibitor, in patients with diarrhea associated with carcinoid syndrome. In this prospective...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Endocr Relat Cancer
Huvudupphovsmän: Kulke, Matthew H., O’Dorisio, Thomas, Phan, Alexandria, Bergsland, Emily, Law, Linda, Banks, Phillip, Freiman, Joel, Frazier, Kenny, Jackson, Jessica, Yao, James C., Kvols, Larry, Lapuerta, Pablo, Zambrowicz, Brian, Fleming, Douglas, Sands, Arthur
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2014
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4295770/
https://ncbi.nlm.nih.gov/pubmed/25012985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-14-0173
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk